Speaker illustration

Doctor Shohei Moriyama

Kyushu University Hospital, Fukuoka (Japan)

Dr. Shohei Moriyama is a medical doctor at Kyushu University Hospital (Japan) and acquired a medical degree at Kyushu University in Fukuoka. Specialization: Cardio-Oncology. Membership: Japanese Circulation Society, Japanese Society of Medical Oncology, and Japanese Onco-Cardiology society.

Renin-angiotensin system inhibitors can be a first choice drug for hypertension in patients treated with vascular endothelial growth factor inhibitors

Event: ESC Congress 2021 - The Digital Experience

Topic: Renin-Angiotensin System

Session: Hypertension e-posters

Thumbnail

Impact of hypertension on clinical outcome in patients treated with vascular endothelial growth factor inhibitors

Event: ESC Congress 2021 - The Digital Experience

Topic: Secondary Hypertension

Session: Hypertension e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk